Table 2.
Spearman correlation coefficient of variables associated with circulating asprosin concentration in the study population.
| r | P value | |
|---|---|---|
| Age (year) | −0.010 | 0.901 |
| Sex (M/F) | −0.014 | 0.866 |
| BMI (kg/m2) | 0.097 | 0.249 |
| Wc (cm) | 0.185 | 0.027 |
| WHR | 0.002 | 0.983 |
| SBP (mmHg) | 0.089 | 0.295 |
| DBP (mmHg) | −0.006 | 0.948 |
| FPG (mmol/L) | 0.466 | <0.001 |
| 2hPG (mmol/L) | 0.277 | 0.003 |
| HbA1c(%/mmol/mol) | 0.368 | <0.001 |
| TC (mmol/L) | 0.017 | 0.840 |
| TG (mmol/L) | 0.282 | 0.001 |
| HDL-C (mmol/L) | −0.143 | 0.088 |
| LDL-C (mmol/L) | −0.038 | 0.652 |
| FINS (mU/L) | 0.131 | 0.120 |
| HOMA-IR | 0.29 | <0.001 |
| HOMA-β | −0.265 | 0.001 |
| AUC | −0.478 | <0.001 |
| AIR | −0.480 | <0.001 |
| GDI | −0.568 | <0.001 |
| hsCRP (mg/L) | 0.086 | 0.313 |
BMI: body mass index; Wc: waist circumference; WHR: waist hip ratio; SBP: systolic blood pressure; DBP: diastolic blood pressure; FPG: fasting plasma glucose; 2hPG; 2 h postchallenge plasma glucose; TC; total cholesterol; TG; triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FINS: fasting serum insulin; HOMA-IR: homeostasis model assessment for insulin resistance; HOMA-β: homeostasis model assessment for beta-cell function; AUC: area under the curve of the first-phase (0–10 min) insulin secretion; AIR: acute insulin response; GDI: glucose disposition index; hsCRP: hypersensitive C-reactive protein.